Literature DB >> 21145874

New assessment of hepatic encephalopathy.

Juan Córdoba1.   

Abstract

Hepatic encephalopathy (HE) is a common complication of cirrhosis that requires careful appraisal of the clinical manifestations, evaluation of the underlying neurological disorders, and assessment of liver function and the portal-systemic circulation. This article reviews recent developments in the assessment of HE and discusses the controversy regarding the use of a categorical or a continuous approach in measuring the severity of this condition. New scales facilitate effective monitoring and assessment of episodic HE. Neuropsychological test batteries and neurophysiological tests are of value for evaluating cognitive function in outpatients and can establish the diagnosis of minimal HE, and the severity of low-grade HE. These tools allow better evaluation of the origin of cognitive complaints and help in estimating the risk of accidents. It is now possible to complete the evaluation with measurement of the effects of cognitive impairment on daily living. In difficult cases, imaging of the brain and portal-systemic circulation with magnetic resonance imaging is especially helpful. Based on these studies, neurological signs and symptoms can be attributed to HE in patients with mild liver disease and in those with complex neurological manifestations. The new methods presented are also valuable for investigating the neurological manifestations occurring after liver transplantation.
Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21145874     DOI: 10.1016/j.jhep.2010.11.015

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  68 in total

Review 1.  Multimodality MR imaging findings of low-grade brain edema in hepatic encephalopathy.

Authors:  L J Zhang; J Zhong; G M Lu
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-01       Impact factor: 3.825

2.  Abnormal spontaneous brain activity in minimal hepatic encephalopathy: resting-state fMRI study.

Authors:  Wei-Jia Zhong; Zhi-Ming Zhou; Jian-Nong Zhao; Wei Wu; Da-Jing Guo
Journal:  Diagn Interv Radiol       Date:  2016 Mar-Apr       Impact factor: 2.630

3.  Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C.

Authors:  Maiko Sakamoto; Steven Paul Woods; Michael Kolessar; Daniel Kriz; J Renee Anderson; Hannah Olavarria; Anna W Sasaki; Michael Chang; Kenneth D Flora; Jennifer M Loftis; Marilyn Huckans
Journal:  J Neurovirol       Date:  2013-09-10       Impact factor: 2.643

Review 4.  Encephalopathy in Wilson disease: copper toxicity or liver failure?

Authors:  Peter Ferenci; Tomasz Litwin; Joanna Seniow; Anna Czlonkowska
Journal:  J Clin Exp Hepatol       Date:  2014-09-22

Review 5.  Definition and nomenclature of hepatic encephalopathy.

Authors:  Narayan Dharel; Jasmohan S Bajaj
Journal:  J Clin Exp Hepatol       Date:  2014-11-28

6.  The confusion assessment method for the intensive care unit in patients with cirrhosis.

Authors:  Eric S Orman; Anthony Perkins; Marwan Ghabril; Babar A Khan; Naga Chalasani; Malaz A Boustani
Journal:  Metab Brain Dis       Date:  2015-05-07       Impact factor: 3.584

Review 7.  Gut microbiota-related complications in cirrhosis.

Authors:  Isabel Gómez-Hurtado; José Such; Yolanda Sanz; Rubén Francés
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

8.  The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Leroy R Thacker; Douglas M Heuman; Michael Fuchs; Richard K Sterling; Arun J Sanyal; Puneet Puri; Mohammad S Siddiqui; Richard T Stravitz; Iliana Bouneva; Velimir Luketic; Nicole Noble; Melanie B White; Pamela Monteith; Ariel Unser; James B Wade
Journal:  Hepatology       Date:  2013-05-23       Impact factor: 17.425

9.  Screening for minimal hepatic encephalopathy in patients with cirrhosis by cirrhosis-related symptoms and a history of overt hepatic encephalopathy.

Authors:  Emi Yoshimura; Tatsuki Ichikawa; Hisamitsu Miyaaki; Naota Taura; Satoshi Miuma; Hidataka Shibata; Takuya Honda; Fuminao Takeshima; Kazuhiko Nakao
Journal:  Biomed Rep       Date:  2016-06-13

Review 10.  Encephalopathy and liver transplantation.

Authors:  Laia Chavarria; Juan Cordoba
Journal:  Metab Brain Dis       Date:  2012-11-16       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.